A longtime leader in healthcare improvement, we’re developing new ways to revolutionize the industry.
Premier provided the FDA and the DEA with a list of reforms and regulatory waivers that should be extended beyond the COVID-19 pandemic.
Premier will support Virginia Mason’s ongoing commitment to effective and efficient supply chain and expense management.
The partnership will help stabilize the long-term supply of propofol, a medication vital for COVID-19 patient care.
Premier’s survey shows local efforts to build stockpiles must be supported with a national strategy to avoid redirecting supplies away from front-line caregivers.
A Premier survey found that the majority of alternate site providers report a more than 50% increase in PPE needs since the COVID-19 outbreak.
Premier plans to strike innovative new partnerships with pharmaceutical companies, putting branded products on negotiated contracts at competitive prices.
These waivers were pressure tested during the pandemic, and proved to be effective at modernizing and improving healthcare delivery.
This new partnership secures supply of amiodarone and sterile water, helping to stabilize the long-term supply of two medications vital for COVID-19 patient care.
The arrangement is part of Premier’s strategy to work with members to invest in domestic and geographically diverse suppliers.
Premier announced a new program to invest in domestic and geographically diverse manufacturers to ensure a robust and resilient supply chain for essential medical products.
Participants in alternative payment models have drawn heavily on their population health capabilities to manage COVID-19.
Premier is leveraging its technology solutions to help hospitals and health systems across the country anticipate surges in COVID-19.
New survey results find that healthcare facilities need to expand their current COVID-19 testing capacity by at least 211% in order to even partially resume...
This dashboard is the industry’s only integrated analytics dashboard that aggregates and benchmarks more than 80 measures to help providers drill into patient-level detail.
Premier's purchasing data shows demand for drugs used to treat cardiovascular conditions and blood clots has soared.
During COVID-19, Premier has adopted the following strategies designed to ensure the effective technology-enablement of provider response efforts to combat the pandemic.
Armed with this early warning about the next shortage on the horizon, manufacturers can adjust the materials used to produce isolation gowns.
States and healthcare providers are contemplating how to best provide care for patients who need medical attention but aren't critical care status.
Premier is coordinating across the industry to help solve the supply chain challenges presented by COVID-19.
The Exchange is a cloud-based platform where hospitals interact with vetted peer organizations to identify and exchange critical medical items.
Premier’s survey is the first to quantify surge capacity and supply burn rates, by category, for the provider community.